Product Information

CEPHALEXIN 500 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1168 per EA under NDC 65862001940. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Nov 16, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Cephalexin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CEPHALEXIN 500 MG CAPSULE

Cephalexin
$0.1168per EA
High Outlier

Strength

500 mg/1

NDC

65862001940

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CEPHALEXIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065253

FDA Approved

11/16/2005

TE Code

AB

On Market Since

11/16/2005

Pharmacological Classes

Price Statistics

The NADAC for CEPHALEXIN 500 MG CAPSULE has been published 677 times since Nov 28, 2013, and over the history we have for it it has risen 9.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1168 per EA
All-time high$0.1576 (Jan 10, 2024)
All-time low$0.0821 (Sep 21, 2016)
52-week high$0.1261
52-week low$0.1168
Median price$0.1111
Average price$0.1096
Largest weekly change-30.2% (Nov 20, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-2.7%

3M

-3.0%

6M

-3.8%

1Y

-8.8%

3Y

-17.7%

5Y

-0.2%

All

+9.8%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CEPHALEXIN 500 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 500 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1168 per EA (NDC 65862001940), effective Nov 11, 2026.

How has the price of CEPHALEXIN 500 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CEPHALEXIN 500 MG CAPSULE has risen 9.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CEPHALEXIN 500 MG CAPSULE?

Since Nov 28, 2013, the NADAC for CEPHALEXIN 500 MG CAPSULE has ranged from a low of $0.0821 (Sep 21, 2016) to a high of $0.1576 (Jan 10, 2024), with a median of $0.1111 per EA.

Are there cheaper alternatives to CEPHALEXIN 500 MG CAPSULE?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEPHALEXIN 500 MG CAPSULE, is $0.0924 per EA — about 21% below CEPHALEXIN 500 MG CAPSULE.

Who manufactures CEPHALEXIN 500 MG CAPSULE?

CEPHALEXIN 500 MG CAPSULE (NDC 65862001940) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.